Publications

Journal Article
Review
Ahead of print
Electronic publication date
May 23, 2026

View on Pubmed.gov 42174362 | View on doi.org 10.1007/s12072-...

Phosphatidylethanol versus clinical criteria to diagnose alcohol use relapse after liver transplantation: a prospective cohort study.

Search for publications in this journal Hepatol Int

Abstract

BACKGROUND

Alcohol-associated liver disease (ALD) with concomitant alcohol use disorder (AUD) is a leading indication for liver transplantation (LT). Return to alcohol use after LT (RAULT) affects a considerable proportion of recipients but lacks an objective diagnostic standard. We evaluated blood phosphatidylethanol (PEth) as a direct biomarker of RAULT and compared it with conventional clinical criteria (ClinC).

METHODS

We prospectively studied adult patients who underwent LT for ALD between 2008 and 2023. Since 2020, RAULT has been assessed quarterly using both ClinC and PEth (cut-off > 0.05 µg/L). Discordant results were interpreted using PEth as a biochemical comparator, given its higher objectivity and specificity compared with ClinC, although it was not considered a definitive diagnostic standard.

RESULTS

Among 143 patients (median age 56 years; 29% female; median post-LT follow-up 72 months), during a 3-year comparative study interval, RAULT was identified in 46 patients (32.2%) by PEth and in 69 patients (48.3%) by ClinC. Concordance between the two methods was observed in 98 cases (68.5%): in 63 cases (44.0%) for absence of RAULT and in 35 cases (24.5%) for presence of RAULT. Discordance occurred in 45 cases (31.5%), including 34 ClinC-positive/PEth-negative cases (23.8%) and 11 ClinC-negative/PEth-positive cases (7.7%). Quarterly and semi-annual PEth testing yielded comparable overall RAULT detection rates; however, quarterly testing identified a higher proportion of severe RAULT (16.1% vs. 12.6%). Time since LT independently predicted RAULT according to PEth (OR = 1.17; 95% CI 1.08-1.27; p = 0.0002).

CONCLUSIONS

Clinical criteria may overestimate the occurrence of RAULT after liver transplantation. Quarterly or semi-annual PEth testing provides additional objective insight into post-transplant alcohol use dynamics and may enhance monitoring of patients with AUD following LT.

References

Skladany L, Adamcova Selcanova S, Koller T. Alcohol use relapse following liver transplantation for alcoholic liver disease. Ann Transplant. 2019;24:359–366. doi.org

Burra P, Sensolo M, Adam R, et al. Liver transplantation for alcoholic liver disease in Europe: a study from the ELTR (European Liver Transplant Registry). Am J Transplant. 2010;10(1):138–148. doi.org

Im GY, Cameron AM, Lucey MR. Liver transplantation for alcoholic hepatitis. J Hepatol. 2019;70(2):328–334. doi.org . (PMID: 30658734)

Beresford TP, Everson GT. Liver transplantation for alcoholic liver disease: bias, beliefs, 6-month rule, and relapse--but where are the data? Liver Transpl. 2000;6(6):777–778. doi.org . (PMID: 11084067)

Conflict of interest statement

Declarations. Conflict of interest: The authors declare no conflicts of interest relevant to this manuscript.

MeSH

Specialties

Copyright

© 2026. The Author(s).